Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Newell

Showing results (371-380 of 519) with videos related to

Pageof 52
Sort By:
Cancer Research|August 15, 1989
Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancersM R Spitz, J J Fueger, N A Beddingfield, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Cisplatin pharmacokinetics in children with cancerB Peng, M W English, A V Boddy, et al.
Cancer Research|December 15, 1988
Comparison of the pharmacokinetics and hepatotoxic effects of saporin and ricin A-chain immunotoxins on murine liver parenchymal cellsD C Blakey, D N Skilleter, R J Price, et al.
Environmental Science & Technology|November 9, 2017
Cultivation of the Ribbed Mussel (Geukensia demissa) for Nutrient Bioextraction in an Urban EstuaryEve Galimany, Gary H Wikfors, Mark S Dixon, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I trial of the anthrapyrazole CI-941: prospective evaluation of a pharmacokinetically guided dose-escalationB J Foster, D R Newell, M A Graham, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1987
Plasma free platinum pharmacokinetics in patients treated with high dose carboplatinD R Newell, Z H Siddik, L A Gumbrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
Pharmacokinetic investigation of imatinib using accelerator mass spectrometry in patients with chronic myeloid leukemiaAlan V Boddy, Julieann Sludden, Melanie J Griffin, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2016
Pre-clinical use of isogenic cell lines and tumours in vitro and in vivo for predictive biomarker discovery; impact of KRAS and PI3KCA mutation status on MEK inhibitor activity is model dependentEmma J Haagensen, Huw D Thomas, Clare Mudd, et al.
British Journal of Cancer|February 1, 1993
Preclinical, phase I and pharmacokinetic studies with the dimethyl phenyltriazene CB10-277B J Foster, D R Newell, J Carmichael, et al.
Journal of the National Cancer Institute|November 1, 1973
Case-control study of Hodgkin's disease. I. Results of the interview questionnaireG R Newell, W Rawlings, B K Kinnear, et al.
Pageof 52

Showing results (371-380 of 519) with videos related to

Sort By:
Pageof 52
Cancer Research|August 15, 1989
Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancersM R Spitz, J J Fueger, N A Beddingfield, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Cisplatin pharmacokinetics in children with cancerB Peng, M W English, A V Boddy, et al.
Cancer Research|December 15, 1988
Comparison of the pharmacokinetics and hepatotoxic effects of saporin and ricin A-chain immunotoxins on murine liver parenchymal cellsD C Blakey, D N Skilleter, R J Price, et al.
Environmental Science & Technology|November 9, 2017
Cultivation of the Ribbed Mussel (Geukensia demissa) for Nutrient Bioextraction in an Urban EstuaryEve Galimany, Gary H Wikfors, Mark S Dixon, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I trial of the anthrapyrazole CI-941: prospective evaluation of a pharmacokinetically guided dose-escalationB J Foster, D R Newell, M A Graham, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1987
Plasma free platinum pharmacokinetics in patients treated with high dose carboplatinD R Newell, Z H Siddik, L A Gumbrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
Pharmacokinetic investigation of imatinib using accelerator mass spectrometry in patients with chronic myeloid leukemiaAlan V Boddy, Julieann Sludden, Melanie J Griffin, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2016
Pre-clinical use of isogenic cell lines and tumours in vitro and in vivo for predictive biomarker discovery; impact of KRAS and PI3KCA mutation status on MEK inhibitor activity is model dependentEmma J Haagensen, Huw D Thomas, Clare Mudd, et al.
British Journal of Cancer|February 1, 1993
Preclinical, phase I and pharmacokinetic studies with the dimethyl phenyltriazene CB10-277B J Foster, D R Newell, J Carmichael, et al.
Journal of the National Cancer Institute|November 1, 1973
Case-control study of Hodgkin's disease. I. Results of the interview questionnaireG R Newell, W Rawlings, B K Kinnear, et al.
Pageof 52